查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1873983

过敏治疗市场

Allergy Treatment Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

预计过敏治疗市场将从2024年的217.7亿美元成长到2031年的335亿美元，2031年至2031年期间的年复合成长率（CAGR）为7.8%。研发投入的增加预计将成为该市场的重要趋势。

过敏治疗市场分析

旨在研发创新抗过敏药物的研发投入增加，预计在不久的将来成为一大趋势。儘管目前市面上已有多种抗过敏药物，但许多呼吸道过敏和气喘患者仅靠对症治疗仍无法有效控制病情或获得充分疗效。例如，某些呼吸道过敏可导致气喘的发生。因此，领先的製药公司正在启动针对过敏症的临床试验项目，例如HAL Allergy BV公司针对呼吸道过敏症推出的「过敏原免疫疗法」。预计研发活动的增加将催生新型抗过敏药物，并在2021年至2031年间显着推动市场成长。

过敏治疗市场概览

根据气喘过敏诊所报道，世界过敏组织（WAO）的最新研究结果表明，14%的人患有气喘，20%的人患有过敏性鼻炎（AR），后者是由IgE介导的鼻粘膜发炎引起的。目前，印度约有20-30%的人口受到一种或多种过敏性疾病的影响，预计未来几年这一比例将持续上升。因此，过敏症发病率的不断增长可能会在未来十年推动抗过敏药物的需求。

战略洞察

过敏治疗市场的驱动因素与机会

过敏症发生率上升推高了对过敏药物的需求

根据美国儿科学会的报告，花粉症（过敏性鼻炎）是最常见的过敏类型，导致巨额治疗费用。过敏治疗的直接和间接费用每年超过70亿美元。有效的过敏治疗取决于病史、过敏测试结果和症状的严重程度。免疫疗法是某些过敏患者的可行治疗选择，主要有两种形式：脱敏针和舌下免疫疗法（SLIT）。脱敏针是指随着时间的推移，逐渐增加过敏原的剂量，帮助患者逐渐降低对这些过敏原的敏感度。这种针剂对花粉、宠物、灰尘、蜜蜂和其他螫刺性昆虫过敏的人以及气喘患者都有效。因此，过敏病例的不断增加是全球过敏治疗市场的主要驱动力。

新药获批带来极具吸引力的市场机会

新药获准用于治疗过敏症，为过敏症治疗市场带来了丰厚的机会。 2020年6月，卡迪拉製药有限公司（Cadila Pharmaceuticals Limited）推出了「比拉斯汀糖浆（30毫升）」和20毫克规格的比拉斯汀片。此外，2022年3月，佩里戈公司（Perrigo Company plc）的「内舒拿® 24小时抗过敏药（糠酸莫米鬆一水合物50微克）」获得了美国食品药品监督管理局（FDA）的最终批准，可以作为非处方药（OTC）使用，这标誌着该公司首个处方药。

过敏治疗市场細項分析

过敏治疗市场分析源自于基于类型、病因、疾病类型、类别和最终用户的关键细分市场。

  • 市场按过敏类型分为眼睛过敏、鼻炎、气喘、皮肤过敏、食物过敏和其他，其中鼻炎在 2023 年占据最大的市场份额。
  • 按治疗类型划分，市场分为抗过敏药物和免疫疗法，其中抗过敏药物在 2023 年占据最大的市场份额。

过敏治疗市场的地理分析

过敏治疗市场报告的地理范围分为五个地区：北美、亚太地区、欧洲、中东和非洲以及南美和中美洲。

北美市场占据主导地位，其中美国在过敏治疗市场占最大份额。该地区拥有众多领先製造商，以及他们研发的具有高效药理特性的创新抗过敏药物，这些因素共同促成了其市场主导地位。预计未来几年，亚太地区将实现最高的复合年增长率。

过敏治疗市场报告范围

过敏治疗市场的最新发展

过敏治疗市场评估是基于从一手和二手研究中收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。过敏治疗市场的主要发展趋势包括：

  • 2024年2月，诺华公司宣布其新上市产品「Xolair（奥马哈珠单抗）」获得美国食品药物管理局（FDA）批准。本产品旨在减少成人和1岁及以上儿童IgE介导的食物过敏患者因意外接触某些食物而引起的过敏反应，包括过敏性休克。 （图片来源：诺华公司网站，2024年2月）

过敏治疗市场报告的覆盖范围和交付成果

这份题为《过敏治疗市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

  • 过敏治疗市场规模及预测，涵盖全球、区域和国家层面的所有关键细分市场。
  • 过敏治疗市场的发展趋势以及市场动态，例如驱动因素、限制因素和关键机会。
  • 深入的PEST/波特五力模型与SWOT分析
  • 对过敏治疗市场进行分析，涵盖关键趋势、全球和区域框架、主要参与者、法规以及近期市场发展动态。
  • 过敏治疗市场的产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展动态
  • 主要公司的详细概况

目录

第一章：引言

第二章：过敏治疗市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：全球过敏治疗市场及市场概况

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 欧洲 PEST 分析
    • 亚太地区PEST分析
    • MEA PEST 分析
    • 骗局害虫分析
  • 专家意见
  • 按地区分類的公司列表

第五章：过敏治疗市场及关键产业动态

  • 主要市场驱动因素
    • 免疫疗法在过敏治疗的应用日益广泛
    • 食物过敏治疗进展
  • 主要市场限制因素
    • 缺乏对过敏治疗的认识
  • 主要市场机会
    • 与过敏相关的研究项目和计划数量不断增加
  • 未来趋势
    • 开发和批准用于治疗过敏和气喘的创新药物，例如生物製剂
  • 影响分析

第六章：过敏治疗市场及全球分析

  • 全球过敏治疗市场收入预测与分析
  • 全球过敏治疗市场（依地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：过敏治疗市场分析及依过敏类型划分

  • 概述
  • 2020 年和 2031 年按过敏类型分類的过敏治疗市场（%）
  • 眼睛过敏
  • 鼻炎
  • 气喘
  • 皮肤过敏
  • 食物过敏
  • 其他过敏

第八章：过敏治疗市场分析及依治疗方式划分

  • 概述
  • 2020 年及 2031 年过敏治疗市场（依治疗方法划分）
  • 抗过敏药物
  • 免疫疗法

第九章：过敏治疗市场及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太
      • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十章：新冠肺炎疫情对全球过敏治疗市场的影响

  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲

第十一章：过敏治疗市场及产业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十二章：公司简介

  • Johnson and Johnson Services, Inc.
  • Sanofi
  • AbbVie Inc.
  • Pfizer Inc.
  • LETI Pharma
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Stallergenes Greer
  • GlaxoSmithKline plc.
  • Dermapharm Holding

第十三章：附录

第十四章：附录

简介目录
Product Code: TIPRE00004584

The allergy treatment market is anticipated to grow from US$ 21.77 billion in 2024 to US$ 33.5 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.8% during the period from 2031 to 2031. Increased research and development (R&D) efforts are expected to be a significant trend in this market.

Analysis of the Allergy Treatment Market

Increased R&D initiatives aimed at creating innovative allergy medications are likely to emerge as a prominent trend in the near future. Although there are numerous allergy medications available, many patients suffering from respiratory allergies and asthma still experience inadequate control or insufficient treatment through symptomatic therapies. For instance, certain respiratory allergies can lead to asthma development. Consequently, leading manufacturers are initiating clinical trial programs focused on allergies, such as HAL Allergy B.V.'s "Allergen Immunotherapies" for respiratory allergies. Thus, the rise in R&D activities is expected to lead to the creation of new anti-allergic medications, significantly contributing to market growth from 2021 to 2031.

Overview of the Allergy Treatment Market

As reported by the Asthma Allergy Clinic, new findings from the World Allergy Organization (WAO) indicate that 14% of individuals have asthma, while 20% suffer from allergic rhinitis (AR), which causes IgE-mediated inflammation of the nasal mucosa. Currently, approximately 20-30% of the population in India is affected by one or more allergic conditions, with this prevalence expected to increase in the coming years. Therefore, the growing incidence of allergies is likely to drive demand for anti-allergic medications over the next decade.

Strategic Insights

Drivers and Opportunities in the Allergy Treatment Market

Increasing Allergy Incidence Boosts Demand for Anti-Allergic Medications

According to a report from the American Academy of Pediatrics, Hay Fever (allergic rhinitis) is the most prevalent type of allergy, contributing to significant treatment costs. The direct and indirect expenses for allergy treatment exceed US$7 billion annually. Effective allergy treatment is based on medical history, allergy test results, and the severity of symptoms. Immunotherapy is a viable treatment option for certain allergy sufferers, with two common forms: allergy shots and sublingual immunotherapy (SLIT). Allergy shots involve administering increasing doses of allergens over time, helping individuals become progressively less sensitive to those allergens. These shots can be effective for people allergic to pollen, pets, dust, bees, and other stinging insects, as well as for asthma sufferers. Thus, the rising number of allergy cases is a major driver for the global allergy treatment market.

New Drug Approvals Present Attractive Market Opportunities

The approval of new drugs for allergy treatment offers lucrative opportunities within the allergy treatment market. In June 2020, Cadila Pharmaceuticals Limited launched "Bilastine Syrup (30ml)" and Bilastine Tablets of 20mg strength. Furthermore, in March 2022, Perrigo Company plc received final approval from the USFDA for the over-the-counter (OTC) use of "Nasonex(R) 24HR Allergy (mometasone furoate monohydrate 50mcg)", marking the company's first Rx-to-OTC switch for "Nasonex" to enter the OTC market.

Segmentation Analysis of the Allergy Treatment Market

The allergy treatment market analysis is derived from key segments based on type, cause, disorder type, category, and end user.

  • The market is segmented by allergy type into eye allergies, rhinitis, asthma, skin allergies, food allergies, and others, with the rhinitis segment holding the largest market share in 2023.
  • By treatment type, the market is divided into anti-allergy drugs and immunotherapies, with the anti-allergy drugs segment capturing the largest market share in 2023.

Geographical Analysis of the Allergy Treatment Market

The geographical scope of the Allergy Treatment market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America leads the market, with the US holding the largest share of the allergy treatment market. The presence of leading manufacturers in the region and their innovative anti-allergic drugs with effective pharmacological properties contribute to this dominance. The Asia Pacific region is expected to experience the highest CAGR in the coming years.

Scope of the Allergy Treatment Market Report

Recent Developments in the Allergy Treatment Market

The Allergy Treatment market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the Allergy Treatment market include:

  • In February 2024, Novartis announced the US Food and Drug Administration (USFDA) approval of "Xolair (omalizumab)", a newly launched product designed to reduce allergic reactions, including anaphylaxis due to accidental exposure to certain foods in adults and pediatric patients aged 1 year and older with IgE-mediated food allergies. (Source: Novartis, Company Website, February 2024)

Coverage and Deliverables of the Allergy Treatment Market Report

The report titled "Allergy Treatment Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Allergy treatment market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Trends in the Allergy Treatment market along with market dynamics such as drivers, restraints, and key opportunities
  • In-depth PEST/Porter's Five Forces and SWOT analysis
  • Analysis of the Allergy Treatment market covering key trends, global and regional frameworks, major players, regulations, and recent market developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments in the Allergy Treatment market
  • Detailed profiles of key companies

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Allergy Treatment Market and By Allergy Type
    • 1.3.2 Allergy Treatment Market and By Treatment
    • 1.3.3 Allergy Treatment Market and By Geography

2. Allergy Treatment Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Allergy Treatment Marketand Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 APAC PEST Analysis
    • 4.2.4 MEA PEST Analysis
    • 4.2.5 SCAM PEST Analysis
  • 4.3 Expert Opinion
  • 4.4 List of Companies, by Region

5. Allergy Treatment Market and Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Adoption of Immunotherapy in Allergy Treatment
    • 5.1.2 Developments in Food Allergy Treatments
  • 5.2 Key Market Restraints
    • 5.2.1 Lack of Awareness About Allergy Treatments
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Number of Allergy-Related Research Projects and Programs
  • 5.4 Future Trends
    • 5.4.1 Development and Approvals of Innovative Medicines such as Biologics for Treating Allergies and Asthma
  • 5.5 Impact Analysis

6. Allergy Treatment Market and Global Analysis

  • 6.1 Global Allergy Treatment Marker Revenue Forecast and Analysis
  • 6.2 Global Allergy Treatment Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Allergy Treatment Market Analysisand by Allergy Type

  • 7.1 Overview
  • 7.2 Allergy Treatment Market, by Allergy Type 2020 and 2031 (%)
  • 7.1 Eye Allergy
    • 7.1.1 Overview
    • 7.1.2 Eye Allergy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.2 Rhinitis
    • 7.2.1 Overview
    • 7.2.2 Rhinitis: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.3 Asthma
    • 7.3.1 Overview
    • 7.3.2 Asthma: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.4 Skin Allergy
    • 7.4.1 Overview
    • 7.4.2 Skin Allergy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.5 Food Allergies
    • 7.5.1 Overview
    • 7.5.2 Food Allergies: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 7.6 Other Allergies
    • 7.6.1 Overview
    • 7.6.2 Other Allergies: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)

8. Allergy Treatment Market Analysisand by Treatment

  • 8.1 Overview
  • 8.2 Allergy Treatment Market, by Treatment 2020 and 2031 (%)
  • 8.3 Anti-Allergy Drugs
    • 8.3.1 Overview
    • 8.3.2 Anti-Allergy Drugs: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.3 Antihistamines
      • 8.3.3.1 Overview
      • 8.3.3.2 Antihistamines: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.4 Corticosteroids
      • 8.3.4.1 Overview
      • 8.3.4.2 Corticosteroids: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.5 Decongestants
      • 8.3.5.1 Overview
      • 8.3.5.2 Decongestants: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.3.6 Other Drug
      • 8.3.6.1 Overview
      • 8.3.6.2 Other Drug: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
  • 8.4 Immunotherapy
    • 8.4.1 Overview
    • 8.4.2 Immunotherapy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.4.3 Sub-cutaneous Immunotherapy (SCIT)
      • 8.4.3.1 Overview
      • 8.4.3.2 Sub-cutaneous Immunotherapy (SCIT): Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
    • 8.4.4 Sub-Lingual Immunotherapy (SLIT)
      • 8.4.4.1 Overview
      • 8.4.4.2 Sub-Lingual Immunotherapy (SLIT): Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)

9. Allergy Treatment Market and Geographical Analysis

  • 9.1 North America: Allergy Treatment Market
    • 9.1.1 Overview
    • 9.1.2 North America: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.1.3 North America: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.1.4 North America: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.1.4.1 North America: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.1.4.2 North America: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.1.5 North America: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.1.6 US: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.6.1 US: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.6.2 US: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.1.6.3 US: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.1.6.3.1 US: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.1.6.3.2 US: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.1.7 Canada: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.7.1 Canada: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.7.2 Canada: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.1.7.3 Canada: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.1.7.3.1 Canada: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.1.7.3.2 Canada: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.1.8 Mexico: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.8.1 Mexico: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.1.8.2 Mexico: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.1.8.3 Mexico: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.1.8.3.1 Mexico: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.1.8.3.2 Mexico: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.2 Europe: Allergy Treatment Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.2.3 Europe: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.2.4 Europe: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.2.4.1 Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.2.4.2 Europe: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.5 Europe: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.2.6 Germany: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.6.1 Germany: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.6.2 Germany: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.6.3 Germany: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.6.3.1 Germany: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.6.3.2 Germany: Allergy Treatment Market, by Immunotherapy 2024 and 2031 (USD Million)
    • 9.2.7 UK: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.7.1 UK: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.7.2 UK: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.7.3 UK: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.7.3.1 UK: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.7.3.2 UK: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.8 France: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.8.1 France: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.8.2 France: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.8.3 France: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.8.3.1 France: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.8.3.2 France: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.9 Italy: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.9.1 Italy: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.9.2 Italy: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.9.3 Italy: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.9.3.1 Italy: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.9.3.2 Italy: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.10 Spain: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.10.1 Spain: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.10.2 Spain: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.10.3 Spain: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.10.3.1 Spain: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.10.3.2 Spain: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.2.11 Rest of Europe: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.11.1 Rest of Europe: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.2.11.2 Rest of Europe: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.2.11.3 Rest of Europe: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.2.11.3.1 Rest of Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.2.11.3.2 Rest of Europe: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.3 Asia-Pacific: Allergy Treatment Market
    • 9.3.1 Overview
    • 9.3.2 Asia-Pacific: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.3.3 Asia-Pacific: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.3.4 Asia-Pacific: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.3.4.1 Asia-Pacific: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.3.4.2 Asia-Pacific ca: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.5 Asia-Pacific: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.3.6 China: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.6.1 China: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.6.2 China: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.6.3 China: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.6.3.1 China: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.6.3.2 China: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.7 Japan: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.7.1 Japan: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.7.2 Japan: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.7.3 Japan: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.7.3.1 Japan: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.7.3.2 Japan: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.8 India: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.8.1 India: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.8.2 India: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.8.3 India: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.8.3.1 India: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.8.3.2 India: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.9 Australia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.9.1 Australia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.9.2 Australia: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.9.3 Australia: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.9.3.1 Australia: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.9.3.2 Australia: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.10 South Korea: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.10.1 South Korea: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.10.2 South Korea: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.10.3 South Korea: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.10.3.1 South Korea: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.10.3.2 South Korea: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.3.11 Rest of Asia-Pacific: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.11.1 Rest of Asia-Pacific: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.3.11.2 Rest of Asia-Pacific: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.3.11.3 Rest of Asia-Pacific: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.3.11.3.1 Rest of Asia-Pacific: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.3.11.3.2 Rest of Asia-Pacific: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.4 Middle East and Africa: Allergy Treatment Market
    • 9.4.1 Overview
    • 9.4.2 Middle East and Africa: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
    • 9.4.3 Middle East and Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
    • 9.4.4 Middle East and Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
      • 9.4.4.1 Middle East and Africa: Allergy Treatment, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
      • 9.4.4.2 Middle East and Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.5 Middle East and Africa: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.4.6 Saudi Arabia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.6.1 Saudi Arabia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.6.2 Saudi Arabia: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.6.3 Saudi Arabia: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.6.3.1 Saudi Arabia: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.6.3.2 Saudi Arabia: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.7 South Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.7.1 South Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.7.2 South Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.7.3 South Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.7.3.1 South Africa: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.7.3.2 South Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.8 UAE: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.8.1 UAE: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.8.2 UAE: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.8.3 UAE: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.8.3.1 UAE: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.8.3.2 UAE: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
    • 9.4.9 Rest of Middle East and Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.9.1 Rest of Middle East and Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.4.9.2 Rest of Middle East and Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
      • 9.4.9.3 Rest of Middle East and Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
        • 9.4.9.3.1 Rest of Middle East and Africa: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
        • 9.4.9.3.2 Rest of Middle East and Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
  • 9.5 South and Central America: Allergy Treatment Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.3 South and Central America Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.4 South and Central America Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
      • 9.5.4.1 South and Central America: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.4.2 South and Central America: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.4.3 South and Central America: Allergy Treatment Market, by Country, 2020 and 2031 (%)
    • 9.5.5 Brazil: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.5.1 Brazil: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.5.2 Brazil Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.5.3 Brazil Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
        • 9.5.5.3.1 Brazil: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
        • 9.5.5.3.2 Brazil: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.6 Argentina: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.1 Argentina: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.2 Argentina Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.3 Argentina Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.4 Argentina: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.6.5 Argentina: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
    • 9.5.7 Rest of South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.7.1 Rest of South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.7.2 Rest of South and Central America Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
      • 9.5.7.3 Rest of South and Central America Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
        • 9.5.7.3.1 Rest of South and Central America: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
        • 9.5.7.3.2 Rest of South and Central America: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)

10. Impact of COVID-19 Pandemic on Global Allergy Treatment Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Allergy Treatment Marketand Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Johnson and Johnson Services, Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sanofi
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 AbbVie Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Pfizer Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 LETI Pharma
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 ALK-Abello A/S
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Allergy Therapeutics
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Stallergenes Greer
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 GlaxoSmithKline plc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Dermapharm Holding
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms